An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome (ALGS)
Clinical trial NCT02047318 · COMPLETED
Trial details
- NCT number
- NCT02047318
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-20
- Primary completion
- 2020-06-17
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.